Home » Topics » BioWorld Science

BioWorld Science
RSS

MediSynergics divulges compounds for parasitic diseases

July 3, 2019

PPNA-40: comparable activity to tigecycline in multidrug-resistant A. baumannii model

July 3, 2019

Strong immunoprotection with a Zika VLP vaccine in a murine model

July 3, 2019

First clinical efficacy and safety data for 225Ac-DOTATATE in GEP-NET

July 3, 2019

ANT-2681 demonstrates pH-dependent potency and in vitro antibacterial activity

July 3, 2019

FDA grants IND approval for phase I/II study of anti-Fc gamma RllB antibody

July 3, 2019

Dicerna to initiate clinical development of DCR-A1AT for A1AT deficiency-associated liver disease

July 3, 2019

Novel zebrafish model to study the role of STUB1 in ataxia

July 3, 2019

MS-1768 acts as a specific dopamine D2 receptor partial agonist

July 3, 2019

Endogenous retrovirus has link to MS

July 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...